Oakbrook Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | $313K | Sell |
642
-3,249
| -84% | -$1.58M | 0.8% | 48 |
|
2019
Q4 | $1.46M | Buy |
3,891
+1,766
| +83% | +$663K | 0.3% | 61 |
|
2019
Q3 | $589K | Buy |
+2,125
| New | +$589K | 0.04% | 351 |
|
2019
Q2 | – | Sell |
-2,960
| Closed | -$1.22M | – | 645 |
|
2019
Q1 | $1.22M | Buy |
+2,960
| New | +$1.22M | 0.07% | 215 |
|
2018
Q2 | – | Sell |
-6,465
| Closed | -$2.23M | – | 601 |
|
2018
Q1 | $2.23M | Buy |
6,465
+3,175
| +97% | +$1.09M | 0.14% | 122 |
|
2017
Q4 | $1.24M | Sell |
3,290
-60
| -2% | -$22.6K | 0.08% | 183 |
|
2017
Q3 | $1.5M | Buy |
3,350
+300
| +10% | +$134K | 0.1% | 166 |
|
2017
Q2 | $1.5M | Sell |
3,050
-3,075
| -50% | -$1.51M | 0.1% | 155 |
|
2017
Q1 | $2.37M | Buy |
+6,125
| New | +$2.37M | 0.15% | 117 |
|
2015
Q1 | – | Sell |
-2,125
| Closed | -$872K | – | 586 |
|
2014
Q4 | $872K | Buy |
+2,125
| New | +$872K | 0.05% | 301 |
|
2014
Q2 | – | Sell |
-12,487
| Closed | -$3.75M | – | 635 |
|
2014
Q1 | $3.75M | Sell |
12,487
-2,000
| -14% | -$601K | 0.12% | 192 |
|
2013
Q4 | $3.99M | Sell |
14,487
-588
| -4% | -$162K | 0.11% | 203 |
|
2013
Q3 | $4.72M | Buy |
15,075
+14,125
| +1,487% | +$4.42M | 0.14% | 166 |
|
2013
Q2 | $214K | Buy |
+950
| New | +$214K | 0.01% | 613 |
|